BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 128373)

  • 1. Predictive tests for malignant hyperpyrexia.
    Isaacs H; Heffron JJ; Badenhorst M
    Br J Anaesth; 1975 Oct; 47(10):1075-80. PubMed ID: 128373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.
    Isaacs H; Heffron JJ
    Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preanesthetic diagnosis of malignant hyperthermia.
    Britt BA
    Int Anesthesiol Clin; 1979; 17(4):63-96. PubMed ID: 391722
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane-induced malignant hyperthermia: creatine phosphate concentration in skeletal muscle as an early indicator of the onset of the syndrome.
    Ahern CP; Somers CJ; Wilson P; McLoughlin JV
    J Comp Pathol; 1980 Apr; 90(2):177-86. PubMed ID: 7430447
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant hyperpyrexia.
    Ellis FR
    Anaesthesia; 1973 May; 28(3):245-52. PubMed ID: 4713948
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill M; Currie S; Harriman DG
    Br Med J; 1975 Aug; 3(5982):511-3. PubMed ID: 1164612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and inheritance of malignant hyperthermia.
    Kalow W; Britt BA; Chan FY
    Int Anesthesiol Clin; 1979; 17(4):119-39. PubMed ID: 391720
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant hyperthermia in a family.
    Kelstrup J; Haase J; Jorni J; Reske-Nielsen E; Hanel HK
    Acta Anaesthesiol Scand; 1973; 17(4):283-4. PubMed ID: 4272689
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for malignant hyperpyrexia.
    Ellis FR; Keaney NP; Harriman DG; Sumner DW; Kyei-Mensah K; Tyrrell JH; Hargreaves JB; Parikh RK; Mulrooney PL
    Br Med J; 1972 Sep; 3(5826):559-61. PubMed ID: 5069639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Serum creatine phosphokinase and malignant hyperpyrexia.
    Ellis FR; Clarke IM; Modgill EM; Currie S; Harriman DG
    Br Med J; 1976 Mar; 1(6009):584. PubMed ID: 1260292
    [No Abstract]   [Full Text] [Related]  

  • 12. Hereditary malignant hyperpyrexia associated with muscle adenylate kinase deficiency.
    Schmitt J; Schmidt K; Ritter H
    Humangenetik; 1974; 24(3):253-7. PubMed ID: 4374418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant hyperthermia].
    Gallo P; Iafrate E
    Recenti Prog Med; 1977 Mar; 62(3):239-61. PubMed ID: 141071
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of halothane on the rate of acid production, lactate production and pyruvate dehydrogenase activity of malignant hyperpyrexia human muscle.
    Bennett D; Cain P; Ellis FR; Halsall J; Louis CF
    Br J Anaesth; 1978 Aug; 50(8):799-803. PubMed ID: 678367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia.
    Isaacs H; Heffron JJ; Badenhorst M
    S Afr Med J; 1975 Nov; 49(46):1923-6. PubMed ID: 795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A halothane-induced biochemical defect in muscle of normal and malignant hyperthermia-susceptible Landrace pigs.
    Mitchell G; Heffron JJ; van Rensburg AJ
    Anesth Analg; 1980 Apr; 59(4):250-6. PubMed ID: 7189363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical studies on malignant hyperpyrexia.
    Pennington RJ; Worsfold M
    Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum creatine phosphokinase activity for the porcine malignant hyperthermia syndrome.
    Heffron JJ; Mitchell G
    Anesth Analg; 1975; 54(4):536-9. PubMed ID: 1170791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant hyperthermia-results of familial investigations in Austria (author's transl)].
    Sporn P
    Wien Klin Wochenschr Suppl; 1981; 132():1-28. PubMed ID: 6952655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.